InsiderTrades

Form 4 for ELVN Enliven Therapeutics, Inc.

Accepted 2025-01-10 00:00:00 ET · period of report 2025-01-07 · accession 0001415889-25-001301 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-01-10 2025-01-07 ELVN Patel Anish COO M - OptEx $1.81 +21.7K 21.7K New +$39.3K
DM 2025-01-10 2025-01-07 ELVN Patel Anish COO S - Sale+OE $24.18 -21.7K 0 -100% -$524.6K
DMI 2025-01-10 2025-01-07 ELVN Patel Anish COO S - Sale+OE $24.18 -6,667 336.6K -2% -$161.2K
DM 2025-01-10 2025-01-07 ELVN Patel Anish COO M - OptEx $0.00 -21.7K 67 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-01-07 M A 10,700 $1.12 10,700 D — —
2 Common Common Stock 2025-01-07 M A 2,000 $2.48 12,700 D — —
3 Common Common Stock 2025-01-07 M A 9,000 $2.48 21,700 D — —
4 Common Common Stock 2025-01-07 S D 20,260 $24.15 1,440 D — — (F2) This transaction was executed in multiple trades at prices ranging from $23.5364 to $24.535. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
5 Common Common Stock 2025-01-07 S D 1,440 $24.56 0 D — — (F3) This transaction was executed in multiple trades at prices ranging from $24.54 to $24.63. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
6 Common Common Stock 2025-01-07 S D 6,577 $24.17 336,734 I See footnote — — (F4) This transaction was executed in multiple trades at prices ranging from $23.595 to $24.585. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. (F5) The shares are held by The Patel / Dong Family Trust.
7 Common Common Stock 2025-01-07 S D 90 $24.60 336,644 I See footnote — — (F6) This transaction was executed in multiple trades at prices ranging from $24.60 to $24.61. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. (F5) The shares are held by The Patel / Dong Family Trust.
8 Derivative Employee Stock Option (right to buy) 2025-01-07 M D 9,000 $0.00 44,342 D $2.48 · — to 2031-03-25 9,000 Common Stock (F8) The option, originally for 75,620 shares, vests in 48 equal monthly installments beginning on January 14, 2021.
9 Derivative Employee Stock Option (right to buy) 2025-01-07 M D 2,000 $0.00 827 D $2.48 · — to 2031-03-25 2,000 Common Stock (F7) All of the shares subject to this option are fully vested and exercisable as of the date hereof.
10 Derivative Employee Stock Option (right to buy) 2025-01-07 M D 10,700 $0.00 67 D $1.12 · — to 2030-06-16 10,700 Common Stock (F7) All of the shares subject to this option are fully vested and exercisable as of the date hereof.